![Minakem Generic APIs](https://www.pharmacompass.com/image/flap/minakem-header-desktop-w27gif-57924.gif)
![Minakem Generic APIs](https://www.pharmacompass.com/image/flap/minakem-header-mobile-w27gif-62411.gif)
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.prnewswire.com/news-releases/ema-grants-orphan-drug-designation-to-neoimmunetechs-nt-i7-for-the-treatment-of-acute-radiation-syndrome-302163015.html
https://www.prnewswire.com/news-releases/neoimmunetechs-new-data-at-asco-2024-highlights-enhanced-benefits-of-combining-nt-i7-with-checkpoint-inhibitors-cpi-in-immuno-oncology-302161746.html
https://www.prnewswire.com/news-releases/neoimmunetechs-nt-i7-in-combination-with-chemotherapy-shows-efficacy-in-colorectal-cancer-at-aacr-meeting-302111608.html
https://www.prnewswire.com/news-releases/neoimmunetech-appoints-dr-luke-oh-phd-as-new-chief-executive-officer-302105682.html
https://www.prnewswire.com/news-releases/fda-grants-orphan-drug-designation-odd-status-to-neoimmunetechs-nt-i7-for-advanced-pancreatic-cancer-treatment-302047851.html
https://www.prnewswire.com/news-releases/neoimmunetech-welcomes-a-new-president-for-its-development-and-business-302034623.html
https://www.prnewswire.com/news-releases/neoimmunetech-and-imugene-enter-into-strategic-research-collaboration-to-improve-cancer-treatments-302011880.html
https://www.prnewswire.com/news-releases/fda-grants-orphan-drug-designation-to-neoimmunetechs-nt-i7-for-the-treatment-of-acute-radiation-syndrome-301993403.html
https://www.prnewswire.com/news-releases/neoimmunetech-to-present-new-advances-on-nt-i7-efineptakin-alfa-at-2023-sitc-annual-meeting-301938965.html
https://www.prnewswire.com/news-releases/neoimmunetech-welcomes-two-new-members-to-its-scientific-advisory-board-301885326.html